MS risk and genetic abnormalities in vitamin D metabolism have been reported in several cases, with genetic abnormalities for CYP27B1 in the cytochrome P450 family gene products, which is a regulator of calcitriol synthesis, influencing MS risk [26]. This evidence concerns the gene CYP27B1 and myeloid sarcoma.